The New York Genome Center (NYGC) announced the launch of the MacMillan Center for the Study of the Non-Coding Cancer Genome, a major new initiative in cancer research to study the role and function of the non-coding genome and epigenome in the evolution, progression, and treatment of multiple cancer types. IICD members Karol Nowicki-Osuch and Simon Tavaré lead a subproject focusing on the application of scDNA-seq and scRNA-seq in the discovery of extrachromosomal DNA and their role in the progression of esophageal cancer.
Read the NYGC press release here.
